Skip to main content

Hill, Mitch C.'s Form 4 filing

Inari Medical, Inc. (NARI) · filed Mar 14, 2024

Accession no.
0001127602-24-010133
Filed
Mar 14, 2024, 4:31 PM ET
Trade date
Mar 12, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $251.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hill, Mitch C.CIK 0001644989Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 12, 2024Common StockMOption exerciseAcquired+6,000$0.457+$2,742189,361Direct
Mar 12, 2024Common StockSSaleDisposed−5,999$41.91−$251,418.09183,362Direct
Mar 12, 2024Common StockSSaleDisposed−1$42.58−$42.58183,361Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 12, 2024Common StockMOption exerciseDisposed−6,000$0.00$088,477Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)